Multi-Center Study of Iron Overload: Pilot Study
NCT01114776
Anemia, Anemia, Aplastic
Oakland, California, United States
View Trial DetailsNCT Number: NCT01913548
The purpose of this study is to demonstrate that a sufficient number of iron-overloaded thalassemia (THAL), Sickle Cell Disease (SCD)and Diamond Blackfan Anemia (DBA) populations with similar duration of chronic transfusion, and age at start of transfusions would be available for a confirmatory study. The study will examine the hypothesis that a chronic inflammatory state in SCD leads to hepcidin- and cytokine-mediated iron withholding within the RES (reticuloendothelial system), lower plasma NTBI (non-transferrin bound iron) levels, less distribution of iron to the heart in SCD.
Looking for future studies?
Notify Me16 year and older
All sexes
Observational
Universitätsklinikum Hamburg-Eppendorf, Hamburg-Eppendorf, Germany
A detailed iron burden, transfusion and chelation history will be obtained from chart review or from participant recall.
Iron burden data will include: 1) documentation of liver iron, and 2) average annual ferritin values.
Transfusion data will include: (1) age at onset of regular transfusions, (2) years of chronic transfusion therapy, and (3) pre-transfusion Hb calculated as average of all assessments for each year.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: March 2010 - July 2013
Patients with similar duration of chronic transfusion and age at onset of chronic transfusion therapy will be identified from 10 participating centers. Detailed information on iron burden and transfusion, medical, and chelation histories will be obtained in order to establish a cohort of patients that could be available for a future powered study of extra-hepatic iron deposition and underlying biochemical mechanisms.
UCSF Benioff Children's Hospital Oakland
Other
Modulation of Iron Deposition in Sickle Cell Disease and Other Hemoglobinopathies SURVEY STUDY
Acronym: MCSIO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01114776
Anemia, Anemia, Aplastic
Oakland, California, United States
View Trial DetailsNCT00176852
Anemia, Anemia, Aplastic
Minneapolis, Minnesota, United States
View Trial DetailsNCT00957931
Anemia, Anemia, Aplastic
Birmingham, Alabama, United States
View Trial DetailsNCT03513328
Acquired Anemia Hemolytic, Acquired Neutropenia in Newborn
Gainesville, Florida, United States
View Trial Details